Medicxi
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Medicxi is an investment firm that focuses on the life sciences sector.
Investor Profile
Medicxi has made 51 investments, with 5 in the past 12 months and 61% as lead.
Stage Focus
- Series A (37%)
- Series B (20%)
- Seed (14%)
- Series Unknown (10%)
- Series D (6%)
- Series C (6%)
- Post Ipo Equity (4%)
- Private Equity (2%)
- Convertible Note (2%)
Country Focus
- United States (51%)
- United Kingdom (25%)
- The Netherlands (8%)
- France (4%)
- Germany (2%)
- Ireland (2%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- China (2%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Switzerland (2%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Medical
- Life Science
- Oncology
- Biopharma
- Manufacturing
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
